Lymphocyte infiltration following allo‐and xenomyoblast transplantation in mdx mice

Muscle & Nerve

Volumn 18, Issue 1, 1995, Pages 39-51

  Asselin, Isabelle ^a   Vilquin, Jean Thomas ^a   Tremblay, Jacques P ^a   Guérette, Benoǐt ^b   Roy, Raynald ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

CD4; CD8; dystrophy; macrophage; mdx mouse; MHC class II; myoblast; T lymphocyte

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DYSTROPHIN; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTEXIN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; X CHROMOSOME; XENOTRANSPLANTATION;

ANIMAL; CADAVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL TRANSPLANTATION; CHILD; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; LYMPHOCYTES; MALE; MICE; MICE, INBRED MDX; MICE, INBRED STRAINS; MUSCLES; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0028814577     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.880180107     Document Type: Article

References (50)

1. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
2. A cDNA clone from the Duchenne/Becker muscular dystrophy gene
3. Predominant naturally processed peptides bound to HLA‐DRI are derived from MHC related molecules and are heterogeneous in size
4. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells
5. Human myoblasts as antigen presenting cells
6. The contribution of exogenous cells to regenerating skeletal muscle: an isoenzyme study of muscle allografts in mice
7. Molecular and cell biology of skeletal muscle regeneration
8. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patidents after myoblast implantation
9. Improved media for normal human muscle satellite cells: Serum‐free clonal growth and enhanced growth with lower serum
10. Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts
11. Myotoxic activity of the crude venom and the principle neurotoxin, taipoxin of the Australian taipan, oxyuranus scutellatus
12. Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin from the venom of the Australian tiger snake, Notechis scutatus scutatus
13. Donord‐directed cytolytic T cells and other inflammatory components of acute allograft rejection
14. Dystrophin: the protein product of the Duchenne muscular dystrophy locus
15. Somatic reversion/suppression of the mouse mdx phenotype in vivo
16. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation
17. Induction of HLA‐DR expression on human myoblasts with interferon‐gamma
18. Human myoblast transplantation: preliminary results of four cases
19. Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice
20. High efficacy of muscle regeneration after human myoblast clone transplantation in SCID mice
21. Identification of self peptides bound to purified HLAB27
22. Myoblast transfer in Duchenne muscular dystrophy
23. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation
24. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
25. The complete sequence of dystrophin predicts a rod‐shaped cytoskeletal protein
26. Self‐peptide released from class II HLA‐DR1 exhibits a hydrophobic two‐residue contact motif
27. Specific cloning of DNA fragments absent from the DNA of a male patient with an X‐chromosome deletion
28. Approche thérapeutique de la dystrophie musculaire de Duchenne par transplantation de myoblastes
29. Immune reactions following myoblast transplantation in mouse muscles
30. Dystrophin production induced by myoblast transfer therapy in duchenne muscular dystrophy
31. Feasibility, safety and efficacy of myoblast transfer therapy in Duchenne muscular dystropy boys
32. In search of the “missing self”: MHC molecules and NK cell recognition
33. The immunologic and ultrastructural characterization of the cellular infiltrate in acute cardiac allograft rejection: prevalence of cell with the natural killer (NK) phonotype
34. Constitutive and cytokine‐induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes
35. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene
36. Normal muscle precursor implants restitute normal histology to degenerating muscle of the mdx mouse
37. Muscle precursor cells invade and repopulate freeze‐killed muscles
38. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse
39. Conversion of mdx myofibres from dystrophin‐negative to ‐Positive by injection of normal myoblasts
40. Cloning of the breakpoint of an Xp21 translocation associated with Duchenne muscular dystrophy
41. Propagation and characterization of lymphocytes from transplant biopsies
42. Major histocompatibility complex (MHC) antigen expression on human myoblasts
43. Tissue destruction resulting from the interaction of cytotoxic T cell and their targets
44. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatement in young boys with Duchenne muscular dystrophy
45. Duchenne muscular dystrophy involving of the DMD gene next to ribosomal RNA genes
46. The Duchenne muscular dystrophy gene products is localized in sarcolemma of human skeletal muscle fibers